Wednesday, February 14, 2018 10:30:01 PM
I just think we have to define how the money flows through the separate entities.
Nemus is one of the most promising cannabis biotech companies in the world nowzl, and all that for around a 50M market cap.
BUT, what will the coming structure be as they raise capital to get 4 drugs through human trials, phase 1 trials, over the next 2 years.
Partners they are seeking for a phase 2.
Grants they WILL get.
I love this idea for the next 2-4 years.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM